[an error occurred while processing this directive] (none)[an error occurred while processing this directive] [an error occurred while processing this directive] [an error occurred while processing this directive]
[ Alumni - Management - Feedback - With Frills - Frames ]
DISCLAIMER: Any opinion expressed by a contributor is to be considered his/her own personal opinion, not the opinion of any other swiss-list member, the swiss-list website managers or the swiss-list committee.
VIEW THIS PAGE ONLINE
Work Smarter, Not Harder
How to Develop Your Company Faster
June 1, 2004 at 7:00PM
This panel will investigate the top 10 ways – in operations, finance and legal – to speed up development of emerging high-growth technology and life science companies to get to the next level or funding round.
Increasingly, venture investors experience pressure from their limited partners to show returns in shorter periods of times. Venture investors themselves would like to see exits for their investments earlier and ideally with a higher degree of certainty of success. This translates into a pressure for emerging companies to show progress and growth in the most effective way: cutting time and inefficiencies but not corners. With limited funds available at the seed stage, but so many things to do, this challenge is even bigger in the very first months of company development.
The panel will explore:
What are the top 10 mistakes?
Where time and money get lost and how it can be recovered?
Where focus on the core operations is needed?
What can be outsourced and how and to whom?
How time-to-closure in financings and business deals can be cut?
The experienced panel will also investigate legal structures to address corporate governance and culture as well as communications – with actual cases and metrics comparing various solutions from the work of the panelists.
DATE & TIME:June 1 at 7:00PM
PLACE:Heller Ehrman White & McAuliffe/Venture Law Group
AGENDA:6:45 - 7:15PM Networking
7:15 - 8:00PM Panel Discussion (interactive)
8:00 - 8:30PM Q&A
ADDRESS:275 Middlefield Road
Refreshments will be provided
Robert Blum, Cytokinetics Inc.
Robert I. Blum has served as our Executive Vice President, Corporate Development and Finance and Chief Financial Officer since January 2004. From October 2001 to December 2003, he served as our Senior Vice President, Corporate Development and Finance and Chief Financial Officer. From July 1998 to September 2001, Mr. Blum was our Vice President, Business Development. Prior to joining us in July 1998, he was Director, Marketing at COR Therapeutics, Inc., a biopharmaceutical company from 1996. From 1991 to 1996, he was Director, Business Development at COR Therapeutics. Prior to this, Mr. Blum performed roles of increasing responsibility in sales, marketing and other pharmaceutical business functions at Marion Laboratories, Inc. and Syntex, Inc. Laboratories. Mr. Blum received B.A. degrees in Human Biology and Economics from Stanford University and a M.B.A. from Harvard Business School.
Jim Robbins, Principal, Business Cluster Development www.clusterdevelopment.com
Jim Robbins founded Business Cluster Development in 1993. BCD has helped twenty organizations with the formation of sector-focused incubators.
Jim is Co-Founder and Executive Director of the Software Business Cluster (SBC), the first software and Internet incubator in California. The National Business Incubation Association named the Software Business Cluster the Randall Whaley Incubator of the Year for 2000. Over $500 Million in venture investment has been made in SBC companies over the last 4 years, and four SBC companies have gone public.
Jim is also Director of the Environmental Business Cluster, with offices in San Jose, CA and China. The EBC was the first environmental incubator in the U.S. when it was formed in 1994. The EBC specializes in technology commercialization of clean and renewable energy technology, and it has commercialization contracts with the California Energy Commission and the U.S. Department of Energy. Jim is a Principal in Panasonic Ventures, a $100 Million dollar investment fund. BCD developed the Panasonic Incubator in 1999. It incubates early stage companies in order to created technology partnerships.
Jim is on the Board of Directors of the National Business Incubation Association (NBIA). He also serves as Vice-Chair of the Pacific Incubation Network, a regional network of more than 75 West Coast incubators.
Jim has 30 years experience in the fields of new business formation, organizational design, technology development and management, business operations and law. In addition to starting his own business to assist communities in the development of sector-focused incubators, he has worked for Digital Equipment Corporation, the U.S. Supreme Court and was a trial attorney.
Jim is a frequent speaker on new business formation, early stage venture funding and industry-focused incubation. His most recent presentations were on Bioscience Incubation and Sector-Focused Incubation at the NBIA national conferences in 2003. He has also participated in case studies of BCD incubators by Harvard University and Stanford University.
Andrew Schwab, Founder and Managing Partner of 5AM Ventures.
Mr. Schwab is also a General Partner of Aravis Venture I, L.P., a European-based life science venture fund. Prior to founding 5AM Ventures, he was a Principal at Bay City Capital. While at BCC since 1999, he led many of the firm's investment and merchant banking activities for such companies as Cubist, Lombard Odier, Metabolex, PTC Therapeutics, Symyx and Syrrx. Prior to joining BCC, Mr. Schwab was Vice President of Business Development at Digital Gene Technologies and a Vice President in the life science investment banking group of Montgomery Securities. He serves on the boards of Miikana Therapeutics, Smart Drug Systems, Ilypsa, and The Cincinnati Children's Hospital Medical Center Advisory Board. Mr. Schwab received a BS with honors in genetics and ethics from Davidson College.
Stephen Thau, Attorney, Heller Ehrman/Venture Law Group
Stephen Thau is a member of Heller Ehrman’s Venture Law Group.
Mr. Thau represents emerging growth companies and venture capital firms, with an emphasis on venture capital financings, corporate partnerships, mergers and acquisitions, and public offerings. He has worked with clients in medical devices (Vascular Architects, Revivant, DURECT Corporation), life sciences and biotechnology (AGY Thearapeutics, Anacor Pharmaceuticals, LJL Biosystems, Vitra Biosystems), software (Scimagix, Ingenuity Systems, Alopa Networks) and semiconductors (Berkana Wireless, Ishoni Networks).
Prior to developing his corporate practice, Mr. Thau practiced intellectual property litigation and securities litigation with a national law firm. Before law school, Mr. Thau was a business strategy consultant with a national strategy consulting firm.
Mr. Thau is a graduate of Harvard University and Stanford Law School.
We acknowledge the generosity and commitment of Heller Ehrman as our event sponsor who helped make this event possible.
If you prefer not to receive e-mail updates from the Women's Technology Cluster,
please send an e-mail to info_at_wtc-sf.org with "Remove" in the subject line
+++++++ KILLMIME removed the following attachment(s):
+++++++++ part2: HTML document text
Startup mailing list
Received on Tue May 25 2004 - 09:25:23 PDT